+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sulindac and ursodeoxycholic acid improve primary biliary cirrhosis in patients not responding to UDCA A prospective controlled pilot study



Sulindac and ursodeoxycholic acid improve primary biliary cirrhosis in patients not responding to UDCA A prospective controlled pilot study



Hepatology 32(4 Pt 2): 309A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035795494

Download citation: RISBibTeXText


Related references

Does ursodeoxycholic acid udca improve the prognosis of primary biliary cirrhosis pbc?. Journal of Hepatology 13(Suppl. 2): S138, 1991

The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study. European Journal of Gastroenterology and Hepatology 14(12): 1369-1376, 2002

Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes. Alimentary Pharmacology and Therapeutics 43(2): 283-293, 2016

A randomized controlled trial of ursodeoxycholic acid udca in primary biliary cirrhosis pbc. European Journal of Clinical Investigation 19(2 Part 2): A15, 1989

Changes induced by ursodeoxycholic acid udca administration on biliary and serum bile acid composition in patients with primary biliary cirrhosis pbc. Hepatology 12(4 Part 2): 995, 1990

Interim evaluation of a prospective double-blind trial of ursodeoxycholic acid versus UDCA plus prednisolone in primary biliary cirrhosis. Gastroenterology 104(4 Suppl. ): A938, 1993

Ursodeoxycholic acid udca influences immune parameters in patients with primary biliary cirrhosis pbc. Hepatology 12(4 Part 2): 957, 1990

Influence of ursodeoxycholic acid udca on bile acid metabolism of patients with primary biliary cirrhosis pbc. Gastroenterology 98(5 Part 2): A590, 1990

Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone. Journal of Hepatology 18(1): 9-14, 1993

Does ursodeoxycholic acid udca influence cell membrane architecture in patients with primary biliary cirrhosis pbc. Gastroenterology 96(5 Part 2): A621, 1989

Cxcr3 Axis In Patients With Primary Biliary Cirrhosis (Pbc). A Novel Mechanism Of Action Of Ursodeoxycholic Acid (Udca). Journal of Hepatology 54: S511-S512, 2011

Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone. Gastroenterologie Clinique et Biologique 34(4-5): 283-287, 2010

The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid. European Journal of Gastroenterology & Hepatology 14(12): 1369-1376, 2002

Effects of different doses of ursodeoxycholic acid udca on liver function indices in patients with icteric primary biliary cirrhosis pbc. Gastroenterology 96(5 Part 2): A575, 1989

Different response to ursodeoxycholic acid udca in primary biliary cirrhosis pbc. Journal of Hepatology 16(Suppl. 1): S68, 1992